Clinical trials
Nasopharyngeal Carcinoma trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 6 |
| Terminated | 5 |
| Unknown status | 4 |
| Not yet recruiting | 3 |
| Active, not recruiting | 3 |
| Withdrawn | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National University Hospital, Singapore | 8 |
| National Cancer Centre, Singapore | 7 |
| National Cancer Institute (NCI) | 3 |
| Johns Hopkins University | 2 |
| Novartis Pharmaceuticals | 2 |
| Celgene | 1 |
| Cullinan Therapeutics Inc. | 1 |
| NRG Oncology | 1 |
| National Cancer Center, Japan | 1 |
| Shanghai Proton and Heavy Ion Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nasopharyngeal Carcinoma | 33 |
| Nasopharyngeal Neoplasms | 9 |
| Epstein-Barr Virus Infections | 4 |
| Head and Neck Neoplasms | 4 |
| Neoplasm Metastasis | 2 |
| Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Recurrence | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Triple Negative Breast Neoplasms | 2 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.